Search for stocks /

Chembond Chemicals Ltd Q2 FY26 – The Water, the Walls & the Witty Woes of a Specialty Chem Wizard


1. At a Glance

Chembond Chemicals Ltd (NSE: CHEMBONDCH) is back with its latest Q2 FY26 results — and oh boy, the numbers might not make your eyes pop, but the company’s restructuring game surely will. With a market cap of ₹408 crore, a P/E of 13.2, and a dividend yield of 0.5%, this is one of those rare mid-sized Indian chemical stories where family legacy meets technical niche. The stock currently trades at ₹151, down almost 19% over the last three months, reminding investors that “chemicals may react, but prices surely overreact.”

The September 2025 quarter reported sales of ₹73 crore and PAT of ₹7.2 crore, reflecting a QoQ revenue dip of 2.65% but a profit rise of 4.9%. A sweet contradiction — falling top line but rising bottom line — much like Indian TV serials: fewer episodes, higher drama. The ROCE stands at a beefy 26.5%, and ROE at 19.2%, both suggesting management isn’t just mixing acids but also cooking decent returns.

With zero debt, a current ratio of 6.1, and a promoter holding of 67.7%, Chembond is the financial equivalent of that disciplined student who tops class without taking tuition.


2. Introduction

Chembond Chemicals has been around since 1974 — which means it has seen Indira Gandhi’s policies, liberalization’s chaos, demonetization’s confusion, and today’s algo-trading memes. What started as a small chemical business has now morphed into a multi-vertical player dealing in water treatment, construction chemicals, and industrial hygiene.

But the real spice came in 2025, when the company pulled off a corporate yoga pose — merging, demerging, and re-listing itself all within one fiscal breath. The NCLT-approved Scheme of Arrangement saw the merger of Chembond Clean Water Technologies Limited and the demerger of the Water Treatment & Construction Chemicals business from its erstwhile arm into the main entity. By July 2025, Chembond got re-listed like a reincarnated chemical sage on both BSE and NSE.

Investors were understandably confused — “Did I just buy Chembond or its cousin’s cousin?” But the clarity post-listing helped investors realize that this was not a shady shell game, but a strategic cleanup to make the water treatment and construction divisions shine brighter.

The new Chembond looks leaner, meaner, and surprisingly greener (figuratively and literally, given their water solutions). And the September quarter marks the first full period after this restructuring, which means the numbers now reflect the reborn entity’s actual performance.


3. Business Model – WTF Do They Even Do?

In simple terms, Chembond Chemicals makes sure your factory’s water behaves, your building doesn’t leak, and your kitchen stays hygienic. They operate across three major verticals:

  1. Water Treatment – The crown jewel. Chembond makes specialty chemicals and systems for industrial water treatment — think cooling towers, boilers, and wastewater systems. Their goal: ensure every drop earns its keep. The latest offerings include the Kem Watreat kits and the upgraded Chembond FLUX monitor, basically smart chemistry meets digital monitoring.
  2. Construction Chemicals – The company’s attempt to make concrete relationships literally stronger. From admixtures and waterproofing agents to sealants and curing compounds, this segment serves the fast-growing infrastructure and housing markets.
  3. Industrial Hygiene – Through a joint venture with Germany’s Calvatis GmbH, Chembond supplies cleaning and hygiene products under the quirky brand DAZZO! Professional. It’s like “Surf Excel meets industrial-grade sanitizer.” With a growing client base in food, dairy, and hospitality, this vertical smells like opportunity — quite literally.

Each vertical feeds into India’s industrial and consumer ecosystem. While giants like Pidilite or Deepak Nitrite hog the limelight, Chembond quietly handles the behind-the-scenes chemistry that keeps factories running and hotels sparkling.


4. Financials Overview

Let’s get to the meat (or should we say molecules) of it. The latest

Join 10,000+ investors who read this every week.
Become a member
error: Content is protected !!